Slovakia - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Slovakia Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry fell by 13.2% year on year. In 2019, the country was ranked number 31 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $4,291,243.82 Million PPP. Slovakia is overtaken by Romania, which was number 30 with $26,524,562.71 Million PPP and is followed by Iceland with $1,474,601.4 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, an increase of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 4,291,243.82 |
| 2018 | 5,191,794.31 |
| 2017 | 6,007,528.68 |
| 2016 | 10,698,567.05 |
| 2015 | 6,327,347.18 |
How does Slovakia rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 30 |
#30
Romania
|
26,524,562.71 | 2019 | +1.3 % | -7.3 % | View data | |
| 31 |
#31
Slovakia
|
4,291,243.82 | 2019 | -17.4 % | -13.2 % | View data | |
| 32 |
#32
Iceland
|
1,474,601.40 | 2019 | +0.9 % | +43.9 % | View data | |